90 related articles for article (PubMed ID: 16733207)
1. BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV.
Atayar C; Kok K; Kluiver J; Bosga A; van den Berg E; van der Vlies P; Blokzijl T; Harms G; Davelaar I; Sikkema-Raddatz B; Martin-Subero JI; Siebert R; Poppema S; van den Berg A
Hum Pathol; 2006 Jun; 37(6):675-83. PubMed ID: 16733207
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.
Wlodarska I; Stul M; De Wolf-Peeters C; Hagemeijer A
Haematologica; 2004 Aug; 89(8):965-72. PubMed ID: 15339680
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.
Renné C; Martín-Subero JI; Hansmann ML; Siebert R
J Mol Diagn; 2005 Aug; 7(3):352-6. PubMed ID: 16049307
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence immunophenotyping and interphase cytogenetics (FICTION) detects BCL6 abnormalities, including gene amplification, in most cases of nodular lymphocyte-predominant Hodgkin lymphoma.
Bakhirev AG; Vasef MA; Zhang QY; Reichard KK; Czuchlewski DR
Arch Pathol Lab Med; 2014 Apr; 138(4):538-42. PubMed ID: 24678684
[TBL] [Abstract][Full Text] [Related]
5. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.
Wlodarska I; Nooyen P; Maes B; Martin-Subero JI; Siebert R; Pauwels P; De Wolf-Peeters C; Hagemeijer A
Blood; 2003 Jan; 101(2):706-10. PubMed ID: 12393409
[TBL] [Abstract][Full Text] [Related]
6. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
7. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
8. FISH analysis with a YAC probe improves detection of LAZ3/BCL6 rearrangement in non-Hodgkin's lymphoma.
Roumier C; Galiègue-Zouitina S; Bastard C; Soenen V; Laï JL; Denis C; Buchonnet G; Kerckaert JP; Cosson A; Fenaux P; Preudhomme C
Hematol J; 2000; 1(2):117-25. PubMed ID: 11920179
[TBL] [Abstract][Full Text] [Related]
9. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
10. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
11. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement.
Wlodarska I; Mecucci C; Stul M; Michaux L; Pittaluga S; Hernandez JM; Cassiman JJ; De Wolf-Peeters C; Van den Berghe H
Genes Chromosomes Cancer; 1995 Sep; 14(1):1-7. PubMed ID: 8527378
[TBL] [Abstract][Full Text] [Related]
13. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
14. Internal DNA deletion within the BCL-6 gene on untranslocated chromosome in non-Hodgkin's lymphoma with 3q27 abnormality.
Nakamura Y; Miki T; Miura I; Hashimoto K; Miura A; Akimoto K; Hirosawa S; Saito K; Enokihara H; Furusawa S; Shishido H
Leukemia; 1996 Apr; 10(4):658-61. PubMed ID: 8618443
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
Kraus MD; Haley J
Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances.
Franke S; Wlodarska I; Maes B; Vandenberghe P; Delabie J; Hagemeijer A; De Wolf-Peeters C
Blood; 2001 Mar; 97(6):1845-53. PubMed ID: 11238128
[TBL] [Abstract][Full Text] [Related]
17. BCL6 gene stays on the der(3) chromosome in a t(3;22) (q27;q11) or t(3;14) (q27;q32) associated with non-Hodgkin's lymphoma.
Kobayashi H; Miki T; Nakamura Y; Kaneko Y
Genes Chromosomes Cancer; 1995 Jul; 13(3):225-6. PubMed ID: 7669745
[No Abstract] [Full Text] [Related]
18. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
19. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
20. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
